Deutsche Bank analyst Pito Chickering raised the firm’s price target on HCA Healthcare to $275 from $240 and keeps a Buy rating on the shares. The analyst says HCA has rallied significantly during Q4 after the volatility around Q4 earnings. Investors are trying to understand how much upside remains with HCA hovering at these levels, Chickering tells investors in a research note.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on HCA: